Skip to content
Screener

Total Current Assets at other companies

Pfizer logo
PfizerPFE
$42.82B-6.6%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$471.18M-14.1%
AbbVie logo
AbbVieABBV
$33.53B+21.2%
Immunome logo
ImmunomeIMNM
$594.31M+83.9%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$756M-20.1%
CTO
Citius Oncology, Inc.CTOR
$29.42M+63.1%

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Market cap$2.3B+1,350%
Enterprise value$2.19B+1,537%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0.0×
Current ratio17.2×+12.6×

Where this comes from

Reported directly by SELLAS Life Sciences Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:01 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001390478-26-000008
Line itemMarch 31, 2026December 31, 2025
Cash and cash equivalents$107,097$71,793
Restricted cash and cash equivalents100100
Prepaid expenses and other current assets3,9723,318
Total current assets111,16975,211
Operating lease right-of-use assets839963
Goodwill1,9141,914
Deposits and other assets255257
Total assets$114,177$78,345

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is SELLAS Life Sciences Group, Inc.'s total current assets?
SELLAS Life Sciences Group, Inc. (SLS) reported total current assets of $111.17M in Q1 2026.
How has SELLAS Life Sciences Group, Inc.'s total current assets changed year-over-year?
SELLAS Life Sciences Group, Inc.'s total current assets increased by 247.7% year-over-year, from $31.97M to $111.17M.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s total current assets?
Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s total current assets has grown at a 15.3% compound annual growth rate (CAGR), from $36.93M to $75.21M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about SELLAS Life Sciences Group, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude